When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic

Chest. 2020 Sep;158(3):892-895. doi: 10.1016/j.chest.2020.04.033. Epub 2020 Apr 29.
No abstract available

Keywords: ADA, adalimumab; COVID-19, coronavirus disease 2019; DMASD, disease-modifying antisarcoid drug; GC, glucocorticoid; SARS; coronavirus disease; diffuse lung disease; immunosuppressives; sarcoidosis; severe acute respiratory syndrome.

Publication types

  • Editorial

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / complications*
  • Coronavirus Infections / epidemiology
  • Disease Management*
  • Humans
  • Pandemics*
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / epidemiology
  • SARS-CoV-2
  • Sarcoidosis / complications
  • Sarcoidosis / therapy*